Liberal groups call on Dem leaders to go bigger on drug price legislation

Liberal groups call on Dem leaders to go bigger on drug price legislation
© Getty

A coalition of leading liberal organizations is calling on House Democratic leaders to take bolder stances in proposing legislation to lower drug prices and go further than allowing Medicare to negotiate drug prices.

“Although Medicare negotiation is a much-needed reform, it is not the only solution needed to reach most Americans,” the letter to House Democratic leaders states. “We need reforms that lower stratospheric launch prices for new drugs and prevent price gouging on existing drugs for all payers.”

ADVERTISEMENT
The letter is signed by a range of groups that are powerful allies of congressional Democrats, including the Center for American Progress, AFL-CIO, AFSCME, Indivisible and Families USA.

The push to go bigger comes as House Democrats are in the process of putting together their drug pricing legislation.

While allowing Medicare to negotiate drug prices has long been a Democratic priority, the groups note that 56 percent of the population is covered by private insurance, so they want drug pricing reforms to apply to them too, not just to people with Medicare.

The Center for American Progress, for example, has a plan to limit drug prices that applies to both public and private insurance.

The letter is addressed to Speaker Nancy PelosiNancy PelosiPelosi uses Trump to her advantage Fake Pelosi video sparks fears for campaigns Trump goes scorched earth against impeachment talk MORE (D-Calif.), House Energy and Commerce Committee Chairman Frank Pallone Jr.Frank Joseph PalloneOvernight Health Care — Presented by PCMA — Senators unveil sweeping bipartisan health care package | House lawmakers float Medicare pricing reforms | Dems offer bill to guarantee abortion access Hillicon Valley: Assange hit with 17 more charges | Facebook removes record 2.2B fake profiles | Senate passes anti-robocall bill | Senators offer bill to help companies remove Huawei equipment Overnight Energy: Democrats ask if EPA chief misled on vehicle emissions | Dem senators want NBC debate focused on climate change | 2020 hopeful John Delaney unveils T climate plan MORE (D-N.J.) and House Ways and Means Committee Chairman Richard NealRichard Edmund NealRepublicans attempt to amend retirement savings bill to include anti-BDS language House votes to boost retirement savings Steyer plans impeachment push targeting Democrats over recess MORE (D-Mass.).

House Democrats are planning to first move a package of “low-hanging fruit” drug pricing measures that are smaller and could receive bipartisan support. The liberal groups did not object to this strategy, noting that: “We believe there may be opportunities to enact into law incremental legislation, such as legislation that makes it easier for generic drugs to come to market.”

It is in the second phase, where Democrats plan to bring forward bigger, more partisan legislation, where the groups want to go beyond just allowing Medicare to negotiate drug prices.

“We appreciate your steadfast efforts to lower prescription drug prices for the American people and stand ready to assist you in any way we can,” the letter states.